CARM
Price
$0.39
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
16.21M
VICP
Price
$1.77
Change
+$0.50 (+39.37%)
Updated
Mar 24 closing price
Capitalization
57.3M
Interact to see
Advertisement

CARM vs VICP

Header iconCARM vs VICP Comparison
Open Charts CARM vs VICPBanner chart's image
Carisma Therapeutics
Price$0.39
Change-$0.00 (-0.00%)
Volume$539.73K
Capitalization16.21M
Vicapsys Life Sciences
Price$1.77
Change+$0.50 (+39.37%)
Volume$100
Capitalization57.3M
CARM vs VICP Comparison Chart in %
Loading...
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CARM vs. VICP commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARM is a Hold and VICP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (CARM: $0.39 vs. VICP: $1.77)
Brand notoriety: CARM and VICP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CARM: 3% vs. VICP: 100%
Market capitalization -- CARM: $16.21M vs. VICP: $57.3M
CARM [@Biotechnology] is valued at $16.21M. VICP’s [@Biotechnology] market capitalization is $57.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CARM’s FA Score shows that 0 FA rating(s) are green whileVICP’s FA Score has 1 green FA rating(s).

  • CARM’s FA Score: 0 green, 5 red.
  • VICP’s FA Score: 1 green, 4 red.
According to our system of comparison, VICP is a better buy in the long-term than CARM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CARM’s TA Score shows that 3 TA indicator(s) are bullish.

  • CARM’s TA Score: 3 bullish, 4 bearish.

Price Growth

CARM (@Biotechnology) experienced а -1.07% price change this week, while VICP (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

CARM is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VICP($57.3M) has a higher market cap than CARM($16.2M). CARM YTD gains are higher at: -7.354 vs. VICP (-74.714).
CARMVICPCARM / VICP
Capitalization16.2M57.3M28%
EBITDA-49.68MN/A-
Gain YTD-7.354-74.71410%
P/E RatioN/AN/A-
Revenue20MN/A-
Total Cash7.74MN/A-
Total Debt2.33MN/A-
FUNDAMENTALS RATINGS
CARM vs VICP: Fundamental Ratings
CARM
VICP
OUTLOOK RATING
1..100
6335
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
1
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5385
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VICP's Valuation (1) in the null industry is significantly better than the same rating for CARM (93). This means that VICP’s stock grew significantly faster than CARM’s over the last 12 months.

VICP's Profit vs Risk Rating (100) in the null industry is in the same range as CARM (100). This means that VICP’s stock grew similarly to CARM’s over the last 12 months.

VICP's SMR Rating (100) in the null industry is in the same range as CARM (100). This means that VICP’s stock grew similarly to CARM’s over the last 12 months.

CARM's Price Growth Rating (53) in the null industry is in the same range as VICP (85). This means that CARM’s stock grew similarly to VICP’s over the last 12 months.

CARM's P/E Growth Rating (100) in the null industry is in the same range as VICP (100). This means that CARM’s stock grew similarly to VICP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CARMVICP
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
18%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
16%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALGN205.563.38
+1.67%
Align Technology
NVCT7.780.05
+0.65%
Nuvectis Pharma
HIMS57.650.33
+0.58%
Hims & Hers Health
VIR5.65-0.11
-1.91%
Vir Biotechnology
ZDAI0.60-0.03
-4.99%
Primega Group Holdings Limited

CARM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CARM has been loosely correlated with EVGN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CARM jumps, then EVGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CARM
1D Price
Change %
CARM100%
-1.62%
EVGN - CARM
59%
Loosely correlated
-2.96%
INSM - CARM
44%
Loosely correlated
+0.42%
PMVP - CARM
33%
Poorly correlated
-2.08%
VCYT - CARM
31%
Poorly correlated
+7.04%
ADPT - CARM
30%
Poorly correlated
+0.84%
More

VICP and

Correlation & Price change

A.I.dvisor tells us that VICP and IONS have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VICP and IONS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VICP
1D Price
Change %
VICP100%
N/A
IONS - VICP
22%
Poorly correlated
+0.23%
GOVX - VICP
22%
Poorly correlated
-2.77%
BPMC - VICP
21%
Poorly correlated
N/A
RVMD - VICP
21%
Poorly correlated
+1.84%
CARM - VICP
21%
Poorly correlated
-1.62%
More